Palmitoyl Tripeptide-38
Functions / Benefits
Quality Specifications
| Specification Item | Standard |
|---|---|
| Grade | Cosmetic Grade |
| Recommended Usage | 0.0001%–0.001% (w/w) in finished formulation |
| Property 1 | ≥98% HPLC |
| Property 2 | White powder |
| Property 3 | Soluble in glycols/ethanol |
Description
Palmitoyl Tripeptide-38, marketed as Matrixyl Synthe'6, is the next-generation matrikine peptide that builds upon the success of the original Matrixyl. It stimulates the synthesis of six major constituents: collagen I, III, IV, fibronectin, hyaluronic acid, and laminin-5.
This comprehensive action profile makes Matrixyl Synthe'6 significantly more powerful than its predecessors. While Matrixyl 3000 primarily targets collagen synthesis, Synthe'6 rebuilds the entire matrix supramolecular structure from the dermal-epidermal junction upward for deeper, more durable wrinkle correction.
Clinical studies demonstrate visible wrinkle reduction beginning at day 14, with progressive improvement through day 56. Crow's feet depth reduction of up to 32% has been reported. The palmitoyl moiety ensures sustained release and enhanced skin penetration for prolonged bioactivity.
COSPEP provides pharmaceutical-grade Palmitoyl Tripeptide-38 for premium anti-aging formulations. Each batch includes comprehensive analytical documentation and formulation guidance for optimal product development.